Identifying Good Candidates for Active Surveillance of Ductal Carcinoma In Situ: Insights from a Large Neoadjuvant Endocrine Therapy Cohort.
Glencer AC, Miller PN, Greenwood H, Maldonado Rodas CK, Freimanis R, Basu A, Mukhtar RA, Brabham C, Kim P, Hwang ES, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky AD, Esserman LJ.
Glencer AC, et al. Among authors: greenwood h.
Cancer Res Commun. 2022 Dec 7;2(12):1579-1589. doi: 10.1158/2767-9764.CRC-22-0263. eCollection 2022 Dec.
Cancer Res Commun. 2022.
PMID: 36970720
Free PMC article.